A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness

Abstract
Health Technology Assessment Volume: 10, Issue: 42, Published in November 2006
Funding Information
  • Health Technology Assessment Programme (04/26/01)

This publication has 0 references indexed in Scilit: